References
- Di Rosa M, Willoughby DA (1971): Screens of antiinflamma-tory drugs. J Pharm Pharmacol 23: 297–298.
- Flower RJ, Gryglewski R, Herbaczyska-Credo K, Vane JR (1972): Effects of antiinflammatory drugs on prostaglandin biosynthesis. Nature New Biol 238: 104–106.
- Flower RJ, Moncada S, Vane RJ (1985): Analgesic-antipyretics and anti-inflammatory agents; drugs employed in the treatment of gout. In: Goodman LS, Gilman A, eds., The Pharmacological Basis of Therapeutics. 6th Ed., pp. 682–728.
- Heptinstall S, Awang DV, Dawson BA, Kindack D, Knight DW, May J (1992): Parthenolide content and bioactivity of feverfew Tanacetum partrhenium (L.). J Pharm Pharmacol 44: 391–395.
- Hutchinson J, Dalziel M (1958): Flora of West Tropical Africa. 2nd Ed. Vol. 1, Part 2. The Whitefrias Press, Ltd, London and Tonbridge, pp. 377–383.
- Hwang D, Fisher NH, Jong BC, Tak H, Kim JK, Lee W (1996): Inhibition of the expression of inducible cyclooxygenase
- and proinflammatory cytokines by sesquiterpene lactones correlates with the inhibition of MAP kinases. Biochem Biophys Res Commun 226: 810–818.
- Mahato SB, Kundu AP (1994): 13C-NMR spectra of pentacyclic triterpenoids. A compilation and some salient features. Phytochemistry 37: 1517–1575.
- Safayhi H, Sailer E-R (1997): Anti-inflammatory actions of pentacyclic triterpenes. Planta Med 63: 487–493.
- Wandji J, Wansi JD, Fuendjiep V, Dagne E, Mulholland DA, Tillequin F, Fomum ZT, Sondengam BL, Nkeh BC, Njamen D (2000): Sesquiterpene lactone and a Friedelane derivative from Drypetes molunduana. Phytochemistry 54: 811–815.